Lactose (India) (BSE 524202)₹104.45−0.52%Pharmaceuticals
In the Mar 2026 quarter (standalone), Lactose (India) reported sales of ₹45.85 Cr, up 64.9% from Mar 2025, and net profit of ₹1.89 Cr, up 190.8% year on year. For the year to Mar 2026, sales were ₹163 Cr and net profit ₹6.01 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27.52 | 24.49 | 32.64 | 29.46 | 29.51 | 30.51 | 28.79 | 27.81 | 39.67 | 41.24 | 36.82 | 45.85 |
| Expenses | 23.69 | 21.05 | 26.87 | 23.27 | 23.89 | 25.45 | 25.77 | 24.37 | 35.13 | 35.89 | 33.70 | 40.74 |
| Operating Profit | 3.76 | 3.38 | 5.70 | 6.10 | 5.56 | 4.99 | 2.96 | 3.40 | 4.46 | 5.24 | 3.05 | 5.00 |
| OPM % | 13.8% | 13.9% | 17.6% | 20.9% | 19.0% | 16.5% | 10.4% | 12.4% | 11.3% | 12.8% | 8.4% | 11.0% |
| Other Income | 0.27 | 0.27 | 0.29 | 0.30 | 0.23 | 0.31 | 0.55 | 0.38 | 0.42 | 0.36 | 0.62 | 0.23 |
| Interest | 1.56 | 1.32 | 1.22 | 1.18 | 1.27 | 1.38 | 1.65 | 1.85 | 1.23 | 1.05 | 1.40 | 1.44 |
| Depreciation | 1.20 | 1.21 | 1.21 | 1.64 | 1.32 | 1.34 | 1.36 | 1.40 | 1.38 | 1.45 | 1.44 | 1.51 |
| Profit before tax | 1.30 | 1.13 | 3.58 | 3.62 | 3.22 | 2.60 | 0.53 | 0.54 | 2.28 | 3.14 | 0.86 | 2.30 |
| Tax % | 26.7% | 28.9% | 27.1% | 33.9% | 29.7% | 22.2% | 59.2% | −18.2% | 34.5% | 31.1% | 40.3% | 18.6% |
| Net Profit | 0.97 | 0.82 | 2.64 | 2.41 | 2.28 | 2.04 | 0.23 | 0.65 | 1.51 | 2.17 | 0.54 | 1.89 |
| EPS (Rs) | 0.75 | 0.63 | 2.08 | 1.90 | 1.79 | 1.60 | 0.16 | 0.50 | 1.18 | 1.71 | 0.41 | 1.48 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34.08 | 36.04 | 31.08 | 41.09 | 40.08 | 35.08 | 46.08 | 66.09 | 114 | 116 | 163 | 164 |
| Expenses | 23.99 | 23.99 | 25.01 | 31.02 | 31.01 | 28.98 | 33.99 | 53.96 | 94.96 | 99.04 | 145 | 145 |
| Operating Profit | 9.97 | 10.97 | 5.98 | 9.96 | 8.97 | 5.98 | 11.96 | 10.95 | 18.93 | 16.93 | 17.94 | 17.75 |
| OPM % | 30.0% | 32.1% | 18.0% | 24.0% | 23.1% | 18.1% | 27.1% | 17.0% | 17.1% | 15.1% | 11.1% | 10.9% |
| Other Income | 0.99 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 0.99 | 1.01 | 1.01 | 1.63 |
| Interest | 4.01 | 4.01 | 5.02 | 5.01 | 6.01 | 5.01 | 5.01 | 6.02 | 5.01 | 6.01 | 5.02 | 5.12 |
| Depreciation | 3.01 | 3.01 | 4.01 | 4.01 | 4.01 | 4.01 | 5.01 | 5.01 | 5.01 | 5.01 | 6.01 | 5.78 |
| Profit before tax | 3.99 | 3.99 | −2.99 | 0.99 | 0.00 | −2.99 | 2.99 | 0.99 | 9.97 | 6.98 | 8.97 | 8.58 |
| Tax % | 28.0% | 36.0% | −52.0% | 33.0% | 30.0% | −24.0% | 23.0% | 18.0% | 30.0% | 25.0% | 30.0% | — |
| Exceptional items | 0.45 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 | 0.02 | 0.00 | — |
| Net Profit | 3.01 | 3.01 | −1.01 | 1.01 | 0.00 | −2.01 | 2.01 | 1.01 | 7.01 | 5.01 | 6.01 | 6.11 |
| EPS (Rs) | 3.16 | 2.86 | −1.31 | 0.70 | 0.06 | −2.16 | 1.94 | 0.95 | 5.38 | 4.09 | 4.80 | 4.78 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.02 | 9.02 | 10.01 | 10.02 | 10.03 | 10.03 | 11.01 | 13.03 | 13.03 | 13.02 | 13.01 | 13.01 |
| Reserves | 7.03 | 12.05 | 17.07 | 22.09 | 24.10 | 24.10 | 24.08 | 27.12 | 28.11 | 35.13 | 46.18 | 52.17 |
| Borrowings | 39.11 | 37.12 | 34.07 | 38.10 | 36.12 | 39.15 | 46.13 | 41.11 | 38.10 | 39.09 | 57.14 | 62.09 |
| Other Liabilities | 25.11 | 26.12 | 24.12 | 13.06 | 11.05 | 10.05 | 7.04 | 10.04 | 22.10 | 14.06 | 18.08 | 56.27 |
| Total Liabilities | 80.27 | 83.31 | 85.27 | 83.27 | 82.30 | 84.33 | 88.26 | 90.30 | 101 | 101 | 133 | 184 |
| Fixed Assets | 62.23 | 61.25 | 64.21 | 63.23 | 60.27 | 62.28 | 59.20 | 59.19 | 56.21 | 55.20 | 52.19 | 69.28 |
| CWIP | 0.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.00 | 3.99 | 0.00 | 0.00 | 0.00 | 9.98 | 0.00 |
| Investments | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 15.04 | 21.07 | 20.07 | 19.04 | 20.04 | 22.05 | 25.06 | 30.10 | 45.13 | 46.10 | 71.24 | 114 |
| Inventories | 2.01 | 6.03 | 6.02 | 7.03 | 8.03 | 9.04 | 8.03 | 7.03 | 23.10 | 17.06 | 25.09 | 56.18 |
| Trade receivables | 5.01 | 8.99 | 9.01 | 4.99 | 7.01 | 7.01 | 6.01 | 11.01 | 12.01 | 15.01 | 22.01 | 33.01 |
| Cash & equivalents | 0.00 | 0.00 | 0.99 | 2.99 | 1.01 | 2.01 | 2.99 | 2.01 | 1.01 | 2.01 | 5.01 | 1.01 |
| Total Assets | 80.27 | 83.31 | 85.27 | 83.27 | 82.30 | 84.33 | 88.26 | 90.30 | 101 | 101 | 133 | 184 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 13.02 | 1.01 | 8.01 | 0.00 | 5.01 | 7.01 | 2.01 | 8.01 | 8.01 | 9.01 | 0.00 | 6.01 |
| Cash from investing activity | −22.93 | 2.99 | −4.98 | −1.99 | −1.99 | −2.99 | −5.98 | −0.99 | −0.99 | −1.99 | −15.94 | −9.97 |
| Cash from financing activity | 9.97 | −4.98 | −2.99 | 3.99 | −4.98 | −3.98 | 4.98 | −7.96 | −7.97 | −5.97 | 18.91 | 0.99 |
| Net cash flow | −1.01 | 0.00 | 0.00 | 3.01 | −2.01 | 0.99 | 1.01 | 0.00 | −1.01 | 1.01 | 2.99 | −4.01 |
| Capex | 22.34 | 1.95 | 4.59 | 2.41 | 2.07 | 3.08 | 5.51 | 1.33 | 1.57 | 2.20 | 14.41 | 10.51 |
| Free cash flow | −10.04 | 0.00 | 3.01 | −2.01 | 3.01 | 4.01 | −3.01 | 7.03 | 6.02 | 7.03 | −14.05 | −5.02 |
| CFO / OP % | 255.0% | 18.0% | 74.0% | 15.1% | 58.1% | 80.1% | 34.0% | 68.0% | 70.0% | 50.0% | 5.0% | 37.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 83 | 96 | 91 | 63 | 62 | 64 | 67 | 90 | 69 | 49 | 68 | 75 |
| Inventory days | 129 | 344 | 440 | 456 | 384 | 471 | 587 | 343 | 344 | 119 | 171 | 217 |
| Days payable | 273 | 340 | 559 | 330 | 242 | 202 | 153 | 195 | 275 | 59 | 74 | 146 |
| Cash conversion cycle | −61 | 100 | −27 | 188 | 204 | 333 | 501 | 238 | 138 | 109 | 165 | 146 |
| Working capital days | −118 | −100 | −107 | 18 | 42 | 59 | 56 | 46 | 56 | 26 | 24 | 18 |
| ROCE % | 8.0% | 13.0% | 15.0% | 4.0% | 9.0% | 8.0% | 3.0% | 10.0% | 9.0% | 18.0% | 13.0% | 11.1% |
For the Mar 2026 quarter, Lactose (India) reported sales of ₹45.85 Cr, up 64.9% year on year and net profit of ₹1.89 Cr, up 190.8% year on year. The operating margin was 11.0%.
Lactose (India)'s sales for the year to Mar 2026 were ₹163 Cr; over the last twelve months they were ₹164 Cr.
Net profit for the year to Mar 2026 was ₹6.01 Cr, and ₹6.11 Cr over the last twelve months. Earnings per share over the same trailing period were ₹4.78.
Lactose (India) reported borrowings of ₹62.09 Cr at Mar 2026, against cash and equivalents of ₹1.01 Cr.
Cash from operations was ₹6.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹5.02 Cr.